Ignite Creation Date:
2024-05-06 @ 10:16 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03207282
Status:
COMPLETED
Last Update Posted:
2021-12-10
First Post:
2017-06-30
Brief Title:
Treatment Resistant Depression in America Latina
Sponsor:
Janssen-Cilag SA
Organization:
Janssen-Cilag SA
Study Overview
Official Title:
Treatment Resistant Depression in America Latina
Status:
COMPLETED
Status Verified Date:
2021-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TRAL
Brief Summary:
The purpose of this study is to estimate the prevalence of Treatment Resistant Depression TRD among Major Depressive Disorder MDD participants being treated in a psychiatry reference site example clinic ambulatory hospital day-hospital in 4 Latin American countries Argentina Brazil Colombia and Mexico and to evaluate all and depression-related healthcare resource utilization in TRD participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 54135419RSD4001 | OTHER | Jannsen Cilag SA | None |